Insulin (INS) resistance associated with hyperestrogenemias occurs in gestational diabetes mellitus (GDM), polycystic ovary syndrome (PCOS), ovarian hyperstimulation syndrome (OHSS), estrogen therapies, metabolic syndrome, and obesity. Here, INS is linked to metabolic syndrome.